Skip to content
Life Sciences Series B Founded 2018

Qnovia

Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals

📍 Richmond, United States · Drug Delivery

Funding snapshot

Last roundSeries B
Amount$16M
Date29 October 2024

About

Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals. The company's products include "RespiRx" a combination drug product for first inhalable prescription NRT (Nicotine Replacement Therapy) for smokers trying to quit smoking and a vibrating mesh nebulizer for optimal delivery to the lungs.

Latest news

No articles yet.

Raising like Qnovia?

Analyze your pitch deck before your next raise.

Analyze My Deck →